Novo Nordisk Forecast, price target & analysts
Novo Nordisk Target price 2025 - Analyst rating & recommendation
Novo Nordisk Classifications & Recommendation:
Novo Nordisk Price Target
| Target Price | DKK780.37 |
| Price | DKK434.05 |
| Potential |
79.79%
register free of charge
|
| Number of Estimates | 27 |
|
27 Analysts have issued a price target Novo Nordisk 2026 .
The average Novo Nordisk target price is DKK780.37.
This is
79.79%
register free of charge
DKK1,150.00
164.95%
register free of charge
DKK415.00
4.39%
register free of charge
|
|
| A rating was issued by 35 analysts: 23 Analysts recommend Novo Nordisk to buy, 10 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Novo Nordisk stock has an average upside potential 2026 of
79.79%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion DKK | 290.40 | 350.03 |
| 25.03% | 20.53% | |
| EBITDA Margin | 50.95% | 50.09% |
| 6.23% | 1.68% | |
| Net Margin | 34.67% | 34.25% |
| 2.89% | 1.21% |
27 Analysts have issued a sales forecast Novo Nordisk 2025 . The average Novo Nordisk sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an Novo Nordisk EBITDA forecast 2025. The average Novo Nordisk EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 Novo Nordisk Analysts have issued a net profit forecast 2025. The average Novo Nordisk net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share DKK | 22.67 | 26.99 |
| 21.42% | 19.06% | |
| P/E | 16.08 | |
| EV/Sales | 5.72 |
19 Analysts have issued a Novo Nordisk forecast for earnings per share. The average Novo Nordisk EPS is
This results in the following potential growth metrics and future valuations:
Current Novo Nordisk Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
| BNP PARIBAS EXANE |
Locked
➜
Locked
|
Locked | Jan 05 2025 |
| DZ BANK |
Locked
➜
Locked
|
Locked | Jan 02 2025 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Dec 23 2024 |
| DNB MARKETS |
Locked
➜
Locked
|
Locked | Dec 22 2024 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Dec 19 2024 |
| GUGGENHEIM SECURITIES LLC |
Locked
➜
Locked
|
Locked | Dec 16 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jan 06 2025 |
|
Locked
BNP PARIBAS EXANE:
Locked
➜
Locked
|
Jan 05 2025 |
|
Locked
DZ BANK:
Locked
➜
Locked
|
Jan 02 2025 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Dec 23 2024 |
|
Locked
DNB MARKETS:
Locked
➜
Locked
|
Dec 22 2024 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Dec 19 2024 |
|
Locked
GUGGENHEIM SECURITIES LLC:
Locked
➜
Locked
|
Dec 16 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
